Radiation-nduced activation of TGF-β signaling pathways in relation to vascular damage in mouse kidneys

Radiation Research

Volumn 171, Issue 2, 2009, Pages 188-197

  Kruse, Jacqueline J C M ^a   Floot, Ben G J ^a   Te Poele, Johannes A M ^a   Russell, Nicola S ^a   Stewart, Fiona A ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVIN RECEPTOR LIKE KINASE 1; BETA ADRENERGIC RECEPTOR; CONNECTIVE TISSUE GROWTH FACTOR; ENDOGLIN; INHIBITOR OF DIFFERENTIATION 1; RNA; SMAD7 PROTEIN; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1; PRIMER DNA; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; BLOOD VESSEL INJURY; CELL MIGRATION; CELL PROLIFERATION; ENDOTHELIUM CELL; FEMALE; IMMUNOHISTOCHEMISTRY; IONIZING RADIATION; IRRADIATION; KIDNEY INJURY; MEDIATOR; MOUSE; NONHUMAN; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RADIATION EXPOSURE; RNA ISOLATION; ANIMAL; C3H MOUSE; GENE EXPRESSION; KIDNEY; METABOLISM; NUCLEOTIDE SEQUENCE; SIGNAL TRANSDUCTION; VASCULARIZATION;

ANIMALS; BASE SEQUENCE; DNA PRIMERS; FEMALE; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; KIDNEY; MICE; MICE, INBRED C3H; POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA;

EID: 59649090468     PISSN: 00337587     EISSN: None     Source Type: Journal    
DOI: 10.1667/RR1526.1     Document Type: Article

References (36)

1. M. E. Robbins and S. M. Bonsib, Radiation nephropathy: a review. Scanning Microsc. 9, 535-560 (1995).
2. J. J. Kruse, J. A. te Poele, N. S. Russell, L. J. Boersma and F. A. Stewart, Microarray analysis to identify molecular mechanisms of radiation-induced microvascular damage in normal tissues. Int. J. Radiat. Oncol. Biol. Phys. 58, 420-426 (2004).
3. A. Kuin, J. J. Kruse and F. A. Stewart, Proteinuria and vascular changes after renal irradiation: the role of reactive oxygen species (ROS) and vascular endothelial growth factor (VEGF). Radiat. Res. 159, 174-181 (2003).
4. J. Folkman and P. A. D'Amore, Blood vessel formation: what is its molecular basis? Cell 87, 1153-1155 (1996).
5. P. Carmeliet, Mechanisms of angiogenesis and arteriogenesis. Nat. Med. 6, 389-395 (2000).
6. M. J. Goumans, G. Valdimarsdottir, S. Itoh, A. Rosendahl, P. Sideras and P. ten Dijke, Balancing the activation state of the endothelium via two distinct TGF-beta type I receptors. EMBO J. 21, 1743-1753 (2002).
7. F. Lebrin, M. Deckers, P. Bertolino and P. ten Dijke, TGF-beta receptor function in the endothelium. Cardiovasc. Res. 65, 599-609 (2005).
8. H. Hayashi, S. Abdollah, Y. Qiu, J. Cai, Y. Y. Xu, B. W. Grinnell, M. A. Richardson, J. N. Topper, M. A. Gimbrone, Jr. and D. Falb, The MAD-related protein Smad7 associates with the TGFbeta receptor and functions as an antagonist of TGFbeta signaling. Cell 89, 1165-1173 (1997).
9. A. Nakao, TGF-β receptor-mediated signalling through Smad2, Smad3 and Smad4. EMBO J. 16, 5353-5362 (1997).
10. H. P. Rodemann and M. Bamberg, Cellular basis ofradiation-induced fibrosis. Radiother. Oncol. 35, 83-90 (1995).
11. P. Reisdorf, D. A. Lawrence, V. Sivan, E. Klising and M. T. Martin, Alteration of transforming growth factor-beta1 response involves down-regulation of Smad3 signaling in myofibroblasts from skin fibrosis. Am. J. Pathol. 159, 263-272 (2001).
12. M. Martin, J. Lefaix and S. Delanian, TGF-beta1 and radiation fibrosis: a master switch and a specific therapeutic target? Int. J. Radiat. Oncol. Biol. Phys. 47, 277-290 (2000).
13. K. C. Flanders, Smad3 as a mediator of the fibrotic response. Int. J. Exp. Pathol. 85, 47-64 (2004).
14. M. K. Phanish, N. A. Wahab, B. M. Hendry and M. E. Dockrell, TGF-beta1-induced connective tissue growth factor (CCN2) expression in human renal proximal tubule epithelial cells requires Ras/MEK/ERK and Smad signalling. Nephron Exp. Nephrol. 100, e156-e165 (2005).
15. F. Stewart, S. Bohlken, A. Begg and H. Bartelink, Renal damage in mice after treatment with cisplatinum alone or in combination with X-irradiation. Int. J. Radiat. Oncol. Biol. Phys. 12, 927-933 (1986).
16. J. J. C. M. Kruse, J. A. M. te Poele, A. Velds, R. M. Kerkhoven, L. J. Boersma, N. S. Russell and F. A. Stewart, Identification of differentially expressed genes in mouse kidney after irradiation using microarray analysis. Radiat. Res. 161, 28-38 (2004).
17. T. Q. Nguyen and R. Goldschmeding, Bone morphogenetic protein-7 and connective tissue growth factor: novel targets for treatment of renal fibrosis? Pharm. Res. 25, 2416-2416 (2008).
18. T. Oikawa, M. Freeman, W. Lo, D. E. Vaughan and A. Fogo, Modulation of plasminogen activator inhibitor-1 in vivo: a new mechanism for the anti-fibrotic effect of renin-angiotensin inhibition. Kidney Int. 51, 64-72 (1997).
19. P. K. Datta, J. E. Moulder, B. L. Fish, E. P. Cohen and E. A. Lianos, TGF-beta 1 production in radiation nephropathy: role of angiotensin II. Int. J. Radiat. Biol. 75, 473-479 (1999).
20. E. T. Grygielko, W. M. Martin, C. Tweed, P. Thornton, J. Harling, D. P. Brooks and N. J. Laping, Inhibition of gene markers of fibrosis with a novel inhibitor of transforming growth factor-beta type I receptor kinase in puromycin-induced nephritis. J. Pharmacol. Exp. Ther. 31, 943-951 (2005).
21. N. A. Wahab, B. S. Weston and R. M. Mason, Modulation of the TGFbeta/Smad signaling pathway in mesangial cells by CTGF/CCN2. Exp. Cell Res. 307, 305-314 (2005).
22. A. Leask and D. J. Abraham, TGF-beta signaling and the fibrotic response. FASEB J. 18, 816-827 (2004).
23. C. Bourgier, V. Haydont, F. Milliat, A. Francois, V. Holler, P. Lasser, J. Bourhis, D. Mathé and M. C. Vozenin-Brotons, Inhibition of Rho kinase modulates radiation induced fibrogenic phenotype in intestinal smooth muscle cells through alteration of the cytoskeleton and connective tissue growth factor expression. Gut 54, 336-343 (2005).
24. V. Haydont, D. Mathé, C. Bourgier, J. Abdelali, J. Aigueperse, J. Bourhis and M. C. Vozenin-Brotons, Induction of CTGF by TGF-beta1 in normal and radiation enteritis human smooth muscle cells: Smad/Rho balance and therapeutic perspectives. Radiother. Oncol. 76, 219-225 (2005).
25. M. Bitzer, G. von Gersdorff, D. Liang, A. Dominguez-Rosales, A. A. Beg, M. Rojkind and E. P. Böttinger, A mechanism of suppression of TGF-beta/SMAD signaling by NF-kappa B/RelA. Genes Dev. 14. 187-197 (2000).
26. C. C. Hou, W. Wang, X. R. Huang, P. Fu, T. H. Chen, D. Sheikh-Hamad and H. Y. Lan, Ultrasound-microbubble-mediated gene transfer of inducible Smad7 blocks transforming growth factor-beta signaling and fibrosis in rat remnant kidney. Am. J. Pathol. 166, 761-771 (2005).
27. A. Letamendia, P. Lastres, L. M. Botella, U. Raab, C. Langa, B. Velasco, L. Attisano and C. Bernabeu, Role of endoglin in cellular responses to transforming growth factor-beta. A comparative study with betaglycan. J. Biol. Chem. 273, 33011-33019 (1998).
28. C. Li, I. N. Hampson, L. Hampson, P. Kumar, C. Bernabeu and S. Kumar, CD105 antagonizes the inhibitory signaling of transforming growth factor beta1 on human vascular endothelial cells. FASEB J. 14, 55-64 (2000).
29. F. Lebrin, M. Deckers, P. Bertolino and P. Ten Dijke, TGF-beta receptor function in the endothelium. Cardiovasc. Res. 65, 599-608 (2005).
30. B. Bodey, B. Bodey, Jr., S. E. Siegel and H. E. Kaiser, Over-expression of endoglin (CD105): a marker of breast carcinoma-induced neovascularization. Anticancer Res. 18, 3621-3628 (1998).
31. J. M. Wang, S. Kumar, A. van Agthoven, P. Kumar, D. Pye and R. D. Hunter, Irradiation induces up-regulation of E9 protein (CD105) in human vascular endothelial cells. Int. J. Cancer 62, 791-796 (1995).
32. T. Sanchez-Elsner, L. M. Botella, B. Velasco, C. Langa and C. Bernabeu, Endoglin expression is regulated by transcriptional cooperation between the hypoxia and transforming growth factor-beta pathways. J. Biol. Chem. 277, 43799-43808 (2002).
33. L. W. van Laake, S. van den Driesche, S. Post, A. Feijen, M. A. Jansen, M. H. Driessens, J. J. Mager, R. J. Snijder, C. J. Westermann and C. L. Mummery, Endoglin has a crucial role in blood cell-mediated vascular repair. Circulation 114, 2288-2297 (2006).
34. A. Rodriguez-Pena, N. Eleno, A. Duwell, M. Arevalo, F. Perez-Barriocanal, O. Flores, N. Docherty, C. Bernabeu, M. Letarte and J. M. Lopez-Novoa, Endoglin upregulation during experimental renal interstitial fibrosis in mice. Hypertension 40, 713-720 (2002).
35. A. Bourdeau, D. J. Dumont and M. Letarte, A murine model of hereditary hemorrhagic telangiectasia. J. Clin. Invest. 104, 1343-1351 (1999).
36. K. A. McAllister, K. M. Grogg, D. W. Johnson, C. J. Gallione, M. A. Baldwin, C. E. Jackson, E. A. Helmbold, D. S. Markel, W. C. McKinnon and J. Murrell, Endoglin, a TGF-beta binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasiatype 1. Nat. Genet. 8, 345-351 (1994).